An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.
Schistosomiasis is a neglected tropical disease that is responsible for almost 300,000 deaths annually. Mass drug administration (MDA) is used worldwide for the control of schistosomiasis, but chemotherapy fails to prevent reinfection with schistosomes, so MDA alone is not sufficient to eliminate th...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae73e03bc4144d068e71898b26df6950 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ae73e03bc4144d068e71898b26df6950 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ae73e03bc4144d068e71898b26df69502021-11-18T06:06:47ZAn immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.1553-73661553-737410.1371/journal.ppat.1004033https://doaj.org/article/ae73e03bc4144d068e71898b26df69502014-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24675823/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Schistosomiasis is a neglected tropical disease that is responsible for almost 300,000 deaths annually. Mass drug administration (MDA) is used worldwide for the control of schistosomiasis, but chemotherapy fails to prevent reinfection with schistosomes, so MDA alone is not sufficient to eliminate the disease, and a prophylactic vaccine is required. Herein, we take advantage of recent advances in systems biology and longitudinal studies in schistosomiasis endemic areas in Brazil to pilot an immunomics approach to the discovery of schistosomiasis vaccine antigens. We selected mostly surface-derived proteins, produced them using an in vitro rapid translation system and then printed them to generate the first protein microarray for a multi-cellular pathogen. Using well-established Brazilian cohorts of putatively resistant (PR) and chronically infected (CI) individuals stratified by the intensity of their S. mansoni infection, we probed arrays for IgG subclass and IgE responses to these antigens to detect antibody signatures that were reflective of protective vs. non-protective immune responses. Moreover, probing for IgE responses allowed us to identify antigens that might induce potentially deleterious hypersensitivity responses if used as subunit vaccines in endemic populations. Using multi-dimensional cluster analysis we showed that PR individuals mounted a distinct and robust IgG1 response to a small set of newly discovered and well-characterized surface (tegument) antigens in contrast to CI individuals who mounted strong IgE and IgG4 responses to many antigens. Herein, we show the utility of a vaccinomics approach that profiles antibody responses of resistant individuals in a high-throughput multiplex approach for the identification of several potentially protective and safe schistosomiasis vaccine antigens.Soraya GazePatrick DriguezMark S PearsonTiago MendesDenise L DoolanAngela TrieuDonald P McManusGeoffrey N GobertMaria Victoria PeriagoRodrigo Correa OliveiraFernanda C CardosoGuilherme OliveiraRie NakajimaAl JasinskasChris HungLi LiangJozelyn PabloJeffrey M BethonyPhilip L FelgnerAlex LoukasPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 10, Iss 3, p e1004033 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Soraya Gaze Patrick Driguez Mark S Pearson Tiago Mendes Denise L Doolan Angela Trieu Donald P McManus Geoffrey N Gobert Maria Victoria Periago Rodrigo Correa Oliveira Fernanda C Cardoso Guilherme Oliveira Rie Nakajima Al Jasinskas Chris Hung Li Liang Jozelyn Pablo Jeffrey M Bethony Philip L Felgner Alex Loukas An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. |
description |
Schistosomiasis is a neglected tropical disease that is responsible for almost 300,000 deaths annually. Mass drug administration (MDA) is used worldwide for the control of schistosomiasis, but chemotherapy fails to prevent reinfection with schistosomes, so MDA alone is not sufficient to eliminate the disease, and a prophylactic vaccine is required. Herein, we take advantage of recent advances in systems biology and longitudinal studies in schistosomiasis endemic areas in Brazil to pilot an immunomics approach to the discovery of schistosomiasis vaccine antigens. We selected mostly surface-derived proteins, produced them using an in vitro rapid translation system and then printed them to generate the first protein microarray for a multi-cellular pathogen. Using well-established Brazilian cohorts of putatively resistant (PR) and chronically infected (CI) individuals stratified by the intensity of their S. mansoni infection, we probed arrays for IgG subclass and IgE responses to these antigens to detect antibody signatures that were reflective of protective vs. non-protective immune responses. Moreover, probing for IgE responses allowed us to identify antigens that might induce potentially deleterious hypersensitivity responses if used as subunit vaccines in endemic populations. Using multi-dimensional cluster analysis we showed that PR individuals mounted a distinct and robust IgG1 response to a small set of newly discovered and well-characterized surface (tegument) antigens in contrast to CI individuals who mounted strong IgE and IgG4 responses to many antigens. Herein, we show the utility of a vaccinomics approach that profiles antibody responses of resistant individuals in a high-throughput multiplex approach for the identification of several potentially protective and safe schistosomiasis vaccine antigens. |
format |
article |
author |
Soraya Gaze Patrick Driguez Mark S Pearson Tiago Mendes Denise L Doolan Angela Trieu Donald P McManus Geoffrey N Gobert Maria Victoria Periago Rodrigo Correa Oliveira Fernanda C Cardoso Guilherme Oliveira Rie Nakajima Al Jasinskas Chris Hung Li Liang Jozelyn Pablo Jeffrey M Bethony Philip L Felgner Alex Loukas |
author_facet |
Soraya Gaze Patrick Driguez Mark S Pearson Tiago Mendes Denise L Doolan Angela Trieu Donald P McManus Geoffrey N Gobert Maria Victoria Periago Rodrigo Correa Oliveira Fernanda C Cardoso Guilherme Oliveira Rie Nakajima Al Jasinskas Chris Hung Li Liang Jozelyn Pablo Jeffrey M Bethony Philip L Felgner Alex Loukas |
author_sort |
Soraya Gaze |
title |
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. |
title_short |
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. |
title_full |
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. |
title_fullStr |
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. |
title_full_unstemmed |
An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. |
title_sort |
immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/ae73e03bc4144d068e71898b26df6950 |
work_keys_str_mv |
AT sorayagaze animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT patrickdriguez animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT markspearson animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT tiagomendes animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT deniseldoolan animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT angelatrieu animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT donaldpmcmanus animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT geoffreyngobert animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT mariavictoriaperiago animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT rodrigocorreaoliveira animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT fernandaccardoso animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT guilhermeoliveira animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT rienakajima animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT aljasinskas animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT chrishung animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT liliang animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT jozelynpablo animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT jeffreymbethony animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT philiplfelgner animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT alexloukas animmunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT sorayagaze immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT patrickdriguez immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT markspearson immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT tiagomendes immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT deniseldoolan immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT angelatrieu immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT donaldpmcmanus immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT geoffreyngobert immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT mariavictoriaperiago immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT rodrigocorreaoliveira immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT fernandaccardoso immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT guilhermeoliveira immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT rienakajima immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT aljasinskas immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT chrishung immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT liliang immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT jozelynpablo immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT jeffreymbethony immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT philiplfelgner immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas AT alexloukas immunomicsapproachtoschistosomeantigendiscoveryantibodysignaturesofnaturallyresistantandchronicallyinfectedindividualsfromendemicareas |
_version_ |
1718424561632935936 |